![Matthew Lehman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Lehman
Directeur Général chez
Koligo Therapeutics, Inc.
Profil
Matthew B. Lehman is currently Chief Executive Officer at Koligo Therapeutics, Inc., and a member of the Association of Clinical Research Professionals and the European Business Association.
Formerly, Mr. Lehman was President, Chief Executive Officer & Director at Callitas Health, Inc. from 2015 to 2016; Chief Executive Officer, MD & Executive Director at Immutep Ltd. from 2013 to 2014; Chief Executive Officer & Executive Director at Koligo Therapeutics Ltd.; and Chief Operating Officer at SPRI Clinical Trials-Global LLC.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of Louisville.
Postes actifs de Matthew Lehman
| Sociétés | Poste | Début |
|---|---|---|
European Business Association | Corporate Officer/Principal | 03/01/2011 |
Association of Clinical Research Professionals
 Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services Operates as a association of clinical research professionals | Corporate Officer/Principal | 03/01/2011 |
Koligo Therapeutics, Inc.
 Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases | Directeur Général | - |
Anciens postes connus de Matthew Lehman
| Sociétés | Poste | Fin |
|---|---|---|
Koligo Therapeutics Ltd.
 Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops, manufacture, and sells transformative cell therapies for the treatment of pancreatic diseases | Directeur Général | 18/02/2021 |
| CALLITAS HEALTH INC. | Directeur Général | 15/03/2016 |
| IMMUTEP LIMITED | Directeur Général | 09/07/2014 |
SPRI Clinical Trials-Global LLC
 SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services Engages in clinical research | Directeur des opérations | - |
Formation de Matthew Lehman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Callitas Health, Inc.
 Callitas Health, Inc. Pharmaceuticals: MajorHealth Technology Develops technologies for monitoring and treatment of obesity, diabetes & other gastroenterological indications | Health Technology |
SPRI Clinical Trials-Global LLC
SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services Engages in clinical research | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immutep Ltd.
 Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics | Health Technology |
University of Louisville
 University of Louisville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Clinical Research Professionals
Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services Operates as a association of clinical research professionals | Commercial Services |
European Business Association | |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases | Health Technology |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops, manufacture, and sells transformative cell therapies for the treatment of pancreatic diseases | Health Technology |
